Japan, Aug. 6 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'HUMAN ANTIBODIES THAT BIND RET AND USE METHODS THEREOF.' Other related details are as follows:

Application Number: JP,2025-085725

Category (FI): A61P25/00,C07K16/28,C12N15/13,C12N15/63@Z,A61K39/395@N,A61P35/00,A61P35/02,A61P29/00,A61P19/02,A61P25/06,A61P19/06,A61P11/02,A61P13/10,A61K45/00,A61K47/68

Stage: Grant (IP right granted following substantive examination.)

Filing Date: May 22, 2025

Publication Date: Aug. 1, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....